Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

Wednesday’s Trading Day
9.36 +0.12 / +1.30%
As of May 27
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
9.35 -0.01 / -0.11%
 
Volume: 700.00
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative treatments for infectious diseases. The company is currently engaged in the development of antivirals for the treatment of chronic hepatitis C infection and resistant bacterial infections. Its products include ACH-3102, ACH-2684, Sovaprevir and ACH-3422. Achillion Pharmaceuticals was founded on August 17, 1998 and is headquartered in New Haven, CT.

Contact Information

Achillion Pharmaceuticals, Inc.
300 George Street
New Haven Connecticut 06511
P:(203) 624-7000
Investor Relations:
(203) 752-5510

Employees

Shareholders

Other institutional48.50%
Mutual fund holders44.16%
Individual stakeholders30.86%

Top Executives

Milind S. DeshpandePresident, Chief Executive Officer & Director
Mary Kay FentonCFO, Secretary, EVP & Investor Relations Contact
David ApelianChief Medical Officer & Executive Vice President
Joseph TruittChief Commercial Officer & Executive VP
Glenn SchulmanHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account